Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | ABBV | TMO |
|---|
| Close | 262.51 | 648.43 |
| Market Cap | $464B | $240B |
| 1M | +4.87% | +10.75% |
| P/E (TTM) | 73.7 | 34.4 |
| Forward P/E | 16.8 | 21.8 |
| P/E 5-Yr Percentile | 51 | 65 |
| P/S | 7.2 | 5.2 |
| P/B | — | 4.6 |
| Dividend Yield | 4.47% | 0.29% |
| Latest Quarter Revenue | $17.0B | $12.0B |
| Revenue YoY | +10.2% | +10.5% |
| Gross Margin | 74.7% | — |
| Latest Quarter EPS | 2.03 | 4.68 |
| Avg Post-Earnings Move | ±1.7% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 2.36% |
| 90-Day Net Insider Buying | −$8.2M | −$38.9M |
ABBV · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
